REDUCEDT+30
Savage Brian
Teva Pharmaceutical Industries · NASDAQ
−2,525 sh · $98.8K
Filed 22 Sept 2026SEC Form 4view source
BlackRock
13F filer
$698.6M
42,987,782 sh
Viking Global Investors
13F filer
$51.1M
2,532,119 sh
Bridgewater Associates
13F filer
$44.9M
1,326,678 sh
Duquesne Family Office
13F filer
$21.2M
624,999 sh
Two Sigma Investments
13F filer
$11.0M
366,791 sh
Greenlight Capital
13F filer
$2.8M
268,470 sh
ARK Investment Management
13F filer
$2.3M
68,653 sh
Savage Brian
Teva Pharmaceutical Industries · NASDAQ
−2,525 sh · $98.8K
Savage Brian
Teva Pharmaceutical Industries · NASDAQ
−314 sh · $12.2K
Savage Brian
Teva Pharmaceutical Industries · NASDAQ
−4,503 sh · $174.2K
Mignone Roberto
Teva Pharmaceutical Industries · NASDAQ
−367,600 sh · $14.4M
Savage Brian
Teva Pharmaceutical Industries · NASDAQ
+4,503 sh · $156.3K
Weiss Amir
Teva Pharmaceutical Industries · NASDAQ
+2,500 sh · $49.0K
Satchi-Fainaro Ronit
Teva Pharmaceutical Industries · NASDAQ
−415 sh · $15.5K
Weiss Amir
Teva Pharmaceutical Industries · NASDAQ
−2,500 sh · $94.1K
Weiss Amir
Teva Pharmaceutical Industries · NASDAQ
−6,945 sh · $261.2K
Lippman Evan
Teva Pharmaceutical Industries · NASDAQ
−18,600 sh · $680.3K